Llwytho...

SUN-413 Dual Endocrinopathies Following Single Dose of Pembrolizumab Therapy

Introduction: Immune related endocrine adverse effects (IReAs) caused by checkpoint inhibitors (CI) used in the treatment of advanced cancers are rare and often under recognized, but they can be potentially life-threatening. Case: A 69 y/o male with stage 4 metastatic colon cancer was evaluated 10 d...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Endocr Soc
Prif Awduron: Parikh, Tanvi, Sharma, Meeta
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Endocrine Society 2019
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552853/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-413
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!